Biosynthesis of Chiral Compounds at Hiray Pharma Solutions

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enzymatic biocatalysts can be expertly designed to catalyze the synthesis of chiral compounds in highly efficient, specific, and selective manners as compared to classical chemical synthesis. This webinar will offer a representative look at some of the research and CDMO projects executed by Hiray Pharma Solutions’ Laboratory of Biocatalysis and Enzyme Engineering. A fundamental background of the science, challenges, and advantages of these projects will be provided. In addition, this webinar will feature a brief tour of Hiray’s brand new small molecule manufacturing facility on the company’s 35-acre campus in Jingmen, China. A brief conclusion will follow along with responses to some key questions which have recently been asked of Hiray.

Speakers:

Mika KwanProject Manager – R&D
Hiray Pharma Solutions

Kavuluru Venkata HemakumarTechnical Support Manager – Technology Department
Hiray Pharma Solutions

Tim Miley – VP of Business Development – North America
Hiray Pharma Solutions


Register Now!

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters